Press Releases

— 09/12/22

Summary Toggle German Federal Social Court Schedules Hearing on Classification of Exoskeleton Medical Devices for Spinal Cord Injured Individuals

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Sept. 12, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the German Federal Social
Read More
— 09/08/22

Summary Toggle ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer

Brings Significant Experience in M&A, Investor Relations, and Financial Strategy MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for
Read More
— 08/09/22

Summary Toggle ReWalk Robotics Reports Second Quarter 2022 Financial Results

Highlights June 8 th Milestone Participation at Biannual CMS HCPCS Public Meeting as Part of Efforts to Gain “Artificial Legs” Benefit Category Classification as Prosthetic for ReWalk Device Has Submitted 510k A pplication for ReWalk Stairs and Curbs Functionality MARLBOROUGH, Mass.
Read More
— 08/03/22

Summary Toggle ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Aug. 03, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022 , at 8:30 AM Eastern time .
Read More
— 08/02/22

Summary Toggle ReWalk Robotics Announces Results of 2022 Annual Meeting

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Aug. 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the results of the Company's
Read More
— 07/21/22

Summary Toggle ReWalk Receives Court Approval for Share Repurchase Program

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , July 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received Israeli
Read More
— 06/23/22

Summary Toggle 100th ReWalk Exoskeleton Supplied in Germany

21-year-old Lukas Gloßner from Nürnberg is the 100th paraplegic in Germany to be provided with a ReWalk Personal Exoskeleton BERLIN , June 23, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd (Nasdaq: RWLK) ("ReWalk" or "the Company"), a leading manufacturer of robotic medical technology for people
Read More
— 06/10/22

Summary Toggle ReWalk Provides Notice of 2022 Annual Meeting of Shareholders

Annual Meeting Will be Held on July 27, 2022 MARLBOROUGH, Mass. & BERLIN & YOKNEAM ILIT, Israel --(BUSINESS WIRE)--Jun. 10, 2022-- ReWalk Robotics Ltd. (Nasdaq: RWLK), (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities,
Read More
— 06/02/22

Summary Toggle ReWalk Robotics Announces Share Repurchase Program

MARLBOROUGH, Mass. BERLIN and YOKNEAM ILIT, Israel , June 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that its Board of Directors
Read More
— 05/26/22

Summary Toggle ReWalk Robotics Files Revised Preliminary Proxy Statement and Issues Letter to Shareholders

Highlights the Company’s Recent Progress and Momentum Towards Value-Enhancing Commercialization and Reimbursement Notes that Current Board and Management Team Have the Right Skill Sets, Institutional Knowledge and Third-Party Relationships to Implement Reimbursement Coverage and Create
Read More

Investors

Press Releases

Keyword Search